Europe also needs agency for postmarketing surveillance.
Garattini
Silvio
S
D016907:Adverse Drug Reaction Reporting Systems; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D017277:Drug Approval; D005060:Europe; D006077:Government Agencies; D007783:Lactones / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib
BMJ. 2004 Nov 27;329(7477):1253
15564236